Jun Li is currently the Head of Oncology at GemPharmatech, focusing on preclinical efficacy and safety evaluations in immuno-oncology. They have previously served as the Director of In Vivo Pharmacology at Biosion and as Group Leader of Study Directors at Biocytogen Pharmaceuticals, where they led preclinical CRO services and provided pharmacology consultations. Jun completed their postdoctoral research at The University of Edinburgh and began their academic journey at the University of Aberdeen, earning both a Bachelor of Science and a PhD in Medical Sciences.
This person is not in the org chart
This person is not in any teams
This person is not in any offices